Online registrations will be opening soon
Join the Event
CME CREDITS
Medical Surgeon (Clinical Pathology,
General Medicine (Family Doctors), Haematology, Internal Medicine, Medical Genetics, Nuclear Medicine, Oncology, Pathological Anatomy, Pharmacology and Clinical Toxicology, Radiology, Radiotherapy),
Biologist, Pharmacist,
Chemist (Analytical Chemistry),
Physicist (Health Physics),
Veterinary
VENUE
Hotel NH Venezia Laguna Palace
Viale Ancona, 2
30172 – Venezia
Italy
OFFICIAL LANGUAGE
English
Simultaneous translation
will not be provided
ABSTRACT SUBMISSION
Abstract guidelines can be downloaded here.
Abstracts must be sent by July 15, 2022 and must focus on the following topics:
Abstract submission opens on June 1st, 2022.
- Animal models of cancer
- Cancer epidemiology
- Cancer genetics, genomics and epigenetics
- Cancer modeling and imaging
- Cancer stem cells
- Cell adhesion, migration, invasion and metastasis
- Cell metabolism
- DNA damage and molecular responses to damage
- Drug resistance
- Malignant pleural mesothelioma
- Molecular pathology
- Nanotechnology
- Novel therapeutic targets and experimental therapeutics
- Oncogenes and tumor suppressor genes
- Pediatric cancer
- Precision medicine
- Prevention and early detection
- Prognostic and predictive biomarkers
- Signal transduction and intracellular trafficking
- System biology and OMICS technologies
- Tumor heterogeneity
- Tumor immunology and immunotherapy
- Tumor microenvironment: inflammation, hypoxia and angiogenesis
INTRODUCTION
The SIC Annual Meeting is the focal point of the Italian cancer research community, where preclinical and clinical scientists gather together to share the latest advances in cancer research and cure. In the last few years, we have witnessed, as never before, the rapid translation of preclinical research into clinical application.
The program of the 62nd SIC Annual Meeting, entitled “The exciting path from preclinical research to clinical application” will focus on the challenges posed by the rapid development of the precision medicine approaches, including the need for a better understanding of tumor heterogeneity and drug resistance mechanisms, and the ongoing efforts necessary for a better patients stratification for radio-, chemo-, targeted- and immune- therapies, to increase the number of patients with durable clinical responses.
The meeting will be of interest for both preclinical and clinical researchers, working in different areas of cancer research.
In light of this broad attendance, we have designed scientific sessions in which most compelling topics will be discussed from different perspectives.
Participants to this CME event will thus have the opportunity to gain new knowledge and discuss several aspects of cancer research, including:
How particular targeted agents, radiotherapy and immunotherapies have been selected for their use, in patients with advanced cancer.
How to integrate the use of molecular profiling to select the most appropriate treatment for each patient.
How to evaluate the role of new emerging drugs and which is the biology underlying their efficacy.
Which are the main mechanisms of drug resistance and how combination therapies may increase treatment response or durability.
For the first time in Venice, SIC this year will also hold an open session dedicated to survivors, patients, care givers and all stakeholders involved in the cancer care. In an interactive round table, it will be discussed why and how research can impact on cancer prevention, treatment and patients’ quality of life.
REGISTRATION FEES
| RESIDENTIAL Before September 16, 2022 | RESIDENTIAL After September 16, 2022 | VIRTUAL Before September 16, 2022 | VIRTUAL After September 16, 2022 |
|
|---|---|---|---|---|
| SIC member | 420,00 € | 500,00 € | 150,00 € | 200,00 € |
| Young SIC member | 280,00 € | 330,00 € | 120,00 € | 150,00 € |
| Non member | 500,00 € | 600,00 € | 200,00 € | 250,00 € |
| Young non member | 380,00 € | 400,00 € | 150,00 € | 200,00 € |
Registration fees include:
- admission to the scientific sessions
- admission to the exhibition area
- name badge and congress kit
- welcome cocktail
- coffee breaks and light lunches
- abstracts
- attendance certificate
- CME certificate
- social dinner
REGISTRATION FEES
| RESIDENTIAL Before September 16, 2022 | RESIDENTIAL After September 16, 2022 |
|
|---|---|---|
| SIC member | 420,00 € | 500,00 € |
| Young SIC member | 280,00 € | 330,00 € |
| Non member | 500,00 € | 600,00 € |
| Young non member | 380,00 € | 400,00 € |
| VIRTUAL Before September 16, 2022 | VIRTUAL After September 16, 2022 |
|
|---|---|---|
| SIC member | 150,00 € | 200,00 € |
| Young SIC member | 120,00 € | 150,00 € |
| Non member | 200,00 € | 250,00 € |
| Young non member | 150,00 € | 200,00 € |
Registration fees include:
- admission to the scientific sessions
- admission to the exhibition area
- name badge and congress kit
- welcome cocktail
- coffee breaks and light lunches
- abstracts
- attendance certificate
- CME certificate
- social dinner
SCIENTIFIC COORDINATORS
Gustavo Baldassarre
Head of the Molecular Oncology Unit,
Centro di Riferimento Oncologico di Aviano (CRO), IRCCS
National Cancer Institute (NCI), Aviano (PN), Italy
Fabio Puglisi
Head of the Department of Medical Oncology,
Centro di Riferimento Oncologico di Aviano (CRO), IRCCS
National Cancer Institute (NCI), Aviano (PN), Italy
Professor of Medical Oncology,
Head of the School of Medical Oncology,
Department of Medicine, University of Udine, Italy.
LOCAL SCIENTIFIC
AND ORGANIZING COMMITTEE
Barbara Belletti
IRCCS Centro di Riferimento Oncologico di Aviano,
Aviano (PN)
Vincenzo Canzonieri
IRCCS Centro di Riferimento Oncologico di Aviano,
Aviano (PN)
Saverio Cinieri
“Sen. Antonio Perrino Hospital”, Brindisi – AIOM President
Pierfranco Conte
IRCCS Istituto Oncologico Veneto – University di Padova
Giannino Del Sal
University of Trieste – IFOM, Milan
Silvia Franceschi
IRCCS Centro di Riferimento Oncologico di Aviano,
Aviano (PN)
Valter Gattei
IRCCS Centro di Riferimento Oncologico di Aviano,
Aviano (PN)
Valentina Guarneri
IRCCS Istituto Oncologico Veneto – University di Padova
Stefano Indraccolo
IRCCS Istituto Oncologico Veneto – University di Padova
Roberta Maestro
IRCCS Centro di Riferimento Oncologico di Aviano, Aviano (PN)
Michele Milella
University of Verona
Paolo Morandi
“Dell’Angelo” Hospital, Mestre (VE)
Flavio Rizzolio
University Ca’ Foscari, Venice
Aldo Scarpa
University of Verona
Agostino Steffan
IRCCS Centro di Riferimento Oncologico di Aviano, Aviano (PN)
Gianluca Tell
University of Udine
SIC SCIENTIFIC BOARD
President
Nicola Normanno
National Cancer Institute, G. Pascale, Napoli
President Elect
Maurizio D’Incalci
Humanitas Research Hospital and Humanitas University, Milano
Past President
Gabriella Sozzi
Fondazione IRCCS National Cancer Institute, Milano
Members Under 35
Ilaria Guerriero
Biogem Institute for Genetic Research G. Salvatore, Ariano Irpino (AV)
Erica Torchiaro
Candiolo Cancer Institute FPO-IRCCS, Torino
Board
Paola Allavena
Humanitas Research Hospital, Milano
Gustavo Baldassarre
IRCCS Centro di Riferimento Oncologico di Aviano, Aviano (PN)
Fabrizio Bianchi
IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo (FG)
Giovanni Blandino
Regina Elena National Cancer Institute, Roma
Antonino Bruno
IRCCS MultiMedica, Milano
Paola Chiarugi
University of Firenze
Federica Di Nicolantonio
University of Torino and Candiolo Cancer Institute FPO-IRCCS
CONGRESS VENUE
A technical, pharmaceutical and publication exhibition will be held in the Congress Venue. For any information, please contact the Organizing Secretariat.
The 62th annual Meeting of the Italian Cancer Sociaty will take place in
Hotel NH Venezia Laguna Palace
Viale Ancona, 2
30172 – Venezia
Italy
GIORNATA APERTA
Venezia, Novembre 16th 2022
La SIC incontra la Società Civile
L’oncologia di precisione:
una realtà dalla prevenzione dalla terapia